Evidence map›Paper›PMID 42317723›Full record

ArticleNew microbes and new infections2026

Twenty-two years of

Abdullah Awadh, Adel Sheerah, Mohanned Alsaeed, Abdulrahman Abbas, Wadee Filimban, Abdullah Bazayd, Abdulfattah Alamri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdullah AwadhCollege of Medicine, King Saud Bin Abdulaziz For Health Sciences, Jeddah, Saudi Arabia.
Adel SheerahCollege of Medicine, King Saud Bin Abdulaziz For Health Sciences, Jeddah, Saudi Arabia.
Mohanned AlsaeedCollege of Medicine, King Saud Bin Abdulaziz For Health Sciences, Jeddah, Saudi Arabia.
Abdulrahman AbbasCollege of Medicine, King Saud Bin Abdulaziz For Health Sciences, Jeddah, Saudi Arabia.
Wadee FilimbanCollege of Medicine, King Saud Bin Abdulaziz For Health Sciences, Jeddah, Saudi Arabia.
Abdullah BazaydCollege of Medicine, King Saud Bin Abdulaziz For Health Sciences, Jeddah, Saudi Arabia.
Abdulfattah AlamriKing Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Retrospective chart review of all culture-confirmed Results: Sixty-six patients (mean age 53.2 years; 53% male) were analyzed. Cancer (51.5%)-predominantly gastrointestinal-and diabetes (43.7%) were primary comorbidities. Fever (58%) and septic shock (18%) were common presentations. High resistance to β-lactams: amoxicillin-clavulanate 25% susceptible, imipenem/meropenem 67%/75%. Aminoglycosides (amikacin 96%) and fluoroquinolones (ciprofloxacin 95%) retained high efficacy. Thirty-day all-cause and sepsis-related mortality were 15% and 12%, respectively. On multivariate analysis, Conclusions:

Indexed as

Aeromonas septicemiaAntimicrobial resistanceBloodstream infectionEmpirical therapyMiddle eastMortalityMultidrug resistanceTertiary care

Identifiers

PMID42317723
PMCPMC13273684

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.